FEATURES OF CYTOKINE PRODUCTION DURING REHABILITATION AFTER COVID-19 IN PEOPLE LIVING IN THE NORTHERN REGIONS OF SIBERIA
Abstract
The coronavirus infection of 2019 (COVID-19) has significantly affected the modern world. Recently, it has been proven that IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IFN-γ and TNF-α play an important role in the inflammatory response of the body to SARS-CoV-2 infection.
Purpose. To study the features of the synthesis of key cytokines in residents of the Turukhansky district of the Krasnoyarsk Territory who underwent COVID-19.
Materials and methods. On the basis of "Turukhanskaya RB", village. Turukhansk, in February 2023, 98 patients were examined, the average age was 58 (± 5 years). Of the 98 participants interviewed, 76 people had an official diagnosis of COVID-19 in the period from October 2020. The study was conducted with the permission of the ethical committee of the Research Institute of Medical Problems of the North. Each participant signed an informed consent form for the examination, according to the Helsinki Declaration of the World Medical Association regulating the conduct of scientific research.
Results. A high IgG titer to SARS-Cov-2 was observed in 99% of the examined, a positive IdM titer to SARS-Cov-2 was in 1% of the examined. In the course of studying the features of the cytokine network in patients with Turukhansk there was a significant decrease in the concentration of α-TNF, IL-1b and IL-10, as well as an increase in IL-2, IL-6 and IL-8 relative to the control group of Krasnoyarsk. α-IFN and IL-4 showed no significant changes and remained within the control range. At the same time, no differences were found between the groups of patients with a confirmed diagnosis of COVID-19 and without it.
Conclusion. The data obtained indicate a high level of homogeneity of the sample in the village . Turukhansk, regardless of the presence of the disease, about the low level of detection and control over the course of COVID-19. We observe the formation of a chronic inflammatory process against the background of the prevalence of pro-inflammatory function and an increase in the concentration of pro-inflammatory cytokines, which can subsequently deplete the body's resources and contribute to the development of additional complications.
Downloads
References
Список литературы
Савченко А.А., Борисов А.Г., Кудрявцев И.В., Беленюк В.Д. Фенотип NK-клеток в динамике послеоперационного периода у больных перитонитом в зависимости от исхода заболевания // Инфекция и иммунитет. 2019. Т. 9, № 3-4. С. 539-548. https://doi.org/10.15789/2220-7619-2019-3-4-539-548.
Савченко А.А., Тихонова Е.П., Беленюк В.Д., Борисов А.Г. Особенности фенотипа В-лимфоцитов у больных хроническим вирусным гепатитом С в зависимости от генотипа вируса (до и после лечения препаратами прямого противовирусного действия) // Инфекционные болезни. 2022. Т. 20, № 1. С. 74-81. https://doi.org/10.20953/1729-9225-2022-1-74-81
Савченко А.А., Цуканов В.В., Кудрявцев И.В., Тонких Ю.Л. Зависимость фенотипического состава Т-лимфоцитов у больных хроническим вирусным гепатитом C от генотипа вируса (до и после лечения препаратами прямого противовирусного действия) // Инфекция и иммунитет. 2021. Т. 11, № 6. С. 1141-1151. https://doi.org/10.15789/2220-7619-ARB-1550
Смольникова М.В., Каспаров Э.В., Беленюк В.Д. Уровень IL-4, IL-5, IL-13 и TNF-α у детей с бронхиальной астмой в зависимости от степени контролирования заболевания // Российский иммунологический журнал. 2019. Т. 13, № 2-1(22). С. 545-547.
Behrens E.M., Koretzky G.A. Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era // Arthritis Rheumatol., 2017, vol. 69, no. 6, pp. 1135-43. https://doi.org/10.1002/art.40071
Favalli E.G., Ingegnoli F., De Lucia O., Cincinelli G. et al. COVID-19 infection and rheumatoid arthritis: Faraway, so close! // Autoimmun Rev., 2020, no. 19(5), pp. 102523. https://doi.org/10.1016/j.autrev.2020.102523
Furuya Y., Satoh T. Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension // Int. J. Rheumatol., 2010, no. 3, p. 720305. https://doi.org/10.1155/2010/720305
Hasanvand A. COVID-19 and the role of cytokines in this disease // Inflammopharmacology, 2022, vol. 30, no. 3, pp. 789-798. https://doi.org/10.1007/s10787-022-00992-2
Luo X.H., Zhu Y. T cell immunobiology and cytokine storm of COVID-19 // Scand. J. Immunol., 2021, vol. 93, no. 3, p. e12989. https://doi.org/10.1111/sji.12989
Qin C., Zhou L. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan // China. Clin Infect Dis., 2020, vol. 71, no. 15, pp. 762-768. https://doi.org/10.1093/cid/ciaa248
Raised troponin and interleukin-6 levels are associated with a poor prognosis in COVID-19 // Cardiac Rhythm News. 2020. https://cardiacrhythmnews.com/raised-troponin-and-interleukin-6-levels-are-associated-with-a-poor-prognosis-in-covid-19/
Renu K., Subramaniam M.D. The role of Interleukin-4 in COVID-19 associated male infertility: a hypothesis // J. ReprodImmunol., 2020, vol. 142, p. 103213. https://doi.org/10.1016/j.jri.2020.103213
Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak // J. Autoimmun. 2020, vol. 109, p. 102433. https://doi.org/10.1016/j.jaut.2020.102433
Savchenko A.A., Kudryavtsev I.V., Isakov D.V. Sadowski I.S. et al. Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome // Pharmaceuticals, 2023, vol. 16, no. 4, p. 537. https://doi.org/10.3390/ph16040537
Schulert G.S., Grom A.A. Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies // Annu. Rev. Med., 2015, vol. 66, pp. 145-159. https://doi.org/10.1146/annurev-med-061813-012806
Siu K.L., Yuen K.S. Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC // FASEB J., 2019, vol. 33, no. 8, pp. 8865-8877. https://doi.org/10.1096/fj.201802418R
Smirnova S., Gorbacheva N., Belenyuk V. et al. Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control // European Respiratory Journal, 2020, vol. 56 (Suppl. 64), p. 1108. https://doi.org/10.1183/13993003.congress-2020.1108
Smolnikova M., Gorbacheva N., Konopleva O., Belenyuk V. et al. IL-2B and IL-13 as the markers for severe asthma in Siberian children // Allergy, 2021, vol. 76 (Suppl. 110), p. 133. https://doi.org/10.1111/all.15095
Tay M.Z., Poh C.M. The trinity of COVID-19: immunity, inflammation and intervention // Nat. Rev. Immunol., 2020, vol. 20, no. 6, p. 363-374. https://doi.org/10.1038/s41577-020-0311-8
Utgaard J.O., Jahnsen F.L. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells // J. Exp. Med., 1998, vol. 188, no. 9, p. 1751-6. https://doi.org/10.1084/jem.188.9.1751
Wang F., Hou H. The laboratory tests and host immunity of COVID-19 patients with different severity of illness // JCI Insight, 2020, no. 5(10), pp. e137799. https://doi.org/10.1172/jci.insight.137799
Yang X., Yu Y., Xu J., Shu H. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study // Lancet Respir Med., 2020, vol. 8, no. 5, pp. 475-81. https://doi.org/10.1016/S2213-2600(20)30079-5
Zhang Q., Bastard P. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 // Science, 2020, no.370 (6515), p. eabd4570. https://doi.org/10.1126/science.abd4570
Zhang W., Zhao Y. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China // ClinImmunol., 2020, no. 214, p. 108393. https://doi.org/10.1016/j.clim.2020.108393
References
Savchenko A.A., Borisov A.G., Kudryavtsev I.V., Belenyuk V.D. Fenotip NK-kletok v dinamike posleoperatsionnogo perioda u bol'nykh peritonitom v zavisimosti ot iskhoda zabolevaniya [Phenotype of NK cells in the dynamics of the postoperative period in patients with peritonitis depending on the outcome of the disease]. Infektsiya i immunitet [Infection and Immunity], 2019, vol. 9, no. 3-4, pp. 539-548. https://doi.org/10.15789/2220-7619-2019-3-4-539-548
Savchenko A.A., Tikhonova E.P., Belenyuk V.D., Borisov A.G. Osobennosti fenotipa V-limfotsitov u bol'nykh khronicheskim virusnym gepatitom S v zavisimosti ot genotipa virusa (do i posle lecheniya preparatami pryamogo protivovirusnogo deystviya) [Peculiarities of the B-lymphocyte phenotype in patients with chronic viral hepatitis C depending on the virus genotype (before and after treatment with direct antiviral drugs)]. Infektsionnye bolezni [Infectious Diseases], 2022, vol. 20, no. 1, pp. 74-81. https://doi.org/10.20953/1729-9225-2022-1-74-81
Savchenko A.A., Tsukanov V.V., Kudryavtsev I.V., Tonkikh Yu.L. Zavisimost' fenotipicheskogo sostava T-limfotsitov u bol'nykh khronicheskim virusnym gepatitom C ot genotipa virusa (do i posle lecheniya preparatami pryamogo protivovirusnogo deystviya) [Dependence of the phenotypic composition of T-lymphocytes in patients with chronic viral hepatitis C on the virus genotype (before and after treatment with direct antiviral drugs)]. Infektsiya i immunitet [Infection and Immunity], 2021, vol. 11, no. 6, pp. 1141-1151. https://doi.org/10.15789/2220-7619-ARB-1550
Smol'nikova M.V., Kasparov E.V., Belenyuk V.D. Uroven' IL-4, IL-5, IL-13 i TNF-α u detey s bronkhial'noy astmoy v zavisimosti ot stepeni kontrolirovaniya zabolevaniya [The level of IL-4, IL-5, IL-13 and TNF-α in children with bronchial asthma depending on the degree of disease control]. Rossiyskiy immunologicheskiy zhurnal [Russian Journal of Immunology], 2019, vol. 13, no. № 2-1(22), pp. 545-547.
Behrens E.M., Koretzky G.A. Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era. Arthritis Rheumatol., 2017, vol. 69, no. 6, pp. 1135-43. https://doi.org/10.1002/art.40071
Favalli E.G., Ingegnoli F., De Lucia O., Cincinelli G. et al. COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun Rev., 2020, no. 19(5), pp. 102523. https://doi.org/10.1016/j.autrev.2020.102523
Furuya Y., Satoh T. Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension. Int. J. Rheumatol., 2010, no. 3, p. 720305. https://doi.org/10.1155/2010/720305
Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology, 2022, vol. 30, no. 3, pp. 789-798. https://doi.org/10.1007/s10787-022-00992-2
Luo X.H., Zhu Y. T cell immunobiology and cytokine storm of COVID-19. Scand. J. Immunol., 2021, vol. 93, no. 3, p. e12989. https://doi.org/10.1111/sji.12989
Qin C., Zhou L. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis., 2020, vol. 71, no. 15, pp. 762-768. https://doi.org/10.1093/cid/ciaa248
Raised troponin and interleukin-6 levels are associated with a poor prognosis in COVID-19. Cardiac Rhythm News. 2020. https://cardiacrhythmnews.com/raised-troponin-and-interleukin-6-levels-are-associated-with-a-poor-prognosis-in-covid-19/
Renu K., Subramaniam M.D. The role of Interleukin-4 in COVID-19 associated male infertility: a hypothesis. J. ReprodImmunol., 2020, vol. 142, p. 103213. https://doi.org/10.1016/j.jri.2020.103213
Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020, vol. 109, p. 102433. https://doi.org/10.1016/j.jaut.2020.102433
Savchenko A.A., Kudryavtsev I.V., Isakov D.V. Sadowski I.S. et al. Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome. Pharmaceuticals, 2023, vol. 16, no. 4, p. 537. https://doi.org/10.3390/ph16040537
Schulert G.S., Grom A.A. Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies. Annu. Rev. Med., 2015, vol. 66, pp. 145-159. https://doi.org/10.1146/annurev-med-061813-012806
Siu K.L., Yuen K.S. Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J., 2019, vol. 33, no. 8, pp. 8865-8877. https://doi.org/10.1096/fj.201802418R
Smirnova S., Gorbacheva N., Belenyuk V. et al. Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control. European Respiratory Journal, 2020, vol. 56 (Suppl. 64), p. 1108. https://doi.org/10.1183/13993003.congress-2020.1108
Smolnikova M., Gorbacheva N., Konopleva O., Belenyuk V. et al. IL-2B and IL-13 as the markers for severe asthma in Siberian children. Allergy, 2021, vol. 76 (Suppl. 110), p. 133. https://doi.org/10.1111/all.15095
Tay M.Z., Poh C.M. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol., 2020, vol. 20, no. 6, p. 363-374. https://doi.org/10.1038/s41577-020-0311-8
Utgaard J.O., Jahnsen F.L. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J. Exp. Med., 1998, vol. 188, no. 9, p. 1751-6. https://doi.org/10.1084/jem.188.9.1751
Wang F., Hou H. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight, 2020, no. 5(10), pp. e137799. https://doi.org/10.1172/jci.insight.137799
Yang X., Yu Y., Xu J., Shu H. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med., 2020, vol. 8, no. 5, pp. 475-81. https://doi.org/10.1016/S2213-2600(20)30079-5
Zhang Q., Bastard P. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science, 2020, no.370 (6515), p. eabd4570. https://doi.org/10.1126/science.abd4570
Zhang W., Zhao Y. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. ClinImmunol., 2020, no. 214, p. 108393. https://doi.org/10.1016/j.clim.2020.108393
Abstract views: 123 PDF Downloads: 20
Copyright (c) 2023 Vasilii D. Belenyuk, Alexander A. Sinyakov, Ekaterina O. Shavrina, Olga L. Moskalenko
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
